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Isolated Langerhans cells were studied for 2 hnmuno-
logic functions, the ability to present antigen to sensi-
tized T lymphocytes and the ability to act as stimulator 
cells for mixed lymphocyte reactions. Langerhans cells 
can perform both of these functions. This fact, with the 
previous finding that Langerhans cells possess surface 
Ia antigens and Fe and C3 receptors, strongly suggests 
that Langerhans cells act as epidermal macrophages. 
The functional studies on Langerhans cells that I wish to 
describe were based on many previous studies on lymphocyte 
and macrophage function. Since the fmdings in Langerhans 
cells can be best understood in the context of these previous 
studies, I will briefly summarize them. 
That lymphocytes from immunized animals proliferate in 
vitro in response to the same antigen was observed about 20 yr 
ago [1,2]. This in vitro reaction, best seen in animals that 
exhibit delayed sensitivity, is now a major correlate of delayed 
hypersensitivity. An enormous effort has been aimed at dissec-
tion of this phenomenon at the molecular level. Various manip-
ulations of this in vitro system have been attempted in a search 
for the immunologic "Holy Grail" (at least of cellular immu-
nologists), namely, the true ·molecular nature of the T cell 
receptor [3]. 
In the course of these many investigations it was unequivo-
cally established that macrophages must be present if this 
antigen-induced proliferation is to take place [ 4-7]. The neces-
sary macrophages can come from an unsensitized animal, but 
they must share surface histocompatibility antigens with the 
sensitized lymphocytes if a successful interaction leading to 
lymphocyte proliferation is to occur [8,9]. About 15 yr ago it 
was observed that when lymphoid cells from histoincompatible 
animals were mixed together, a proliferative response (called a 
mixed lymphocyte reaction [10,11]) occurred after 5 to 7 days. 
After strenuous efforts it was again shown that proliferation of 
T lymphocytes requires the presence of macrophages acting as 
principal stimulator cells (12]; no prior sensitization is neces-
sary, and the macrophages must be histoincompatible with the 
responding T lymphocytes. The histocompatibility regions that 
are most important in both exogenous antigen-induced in vitro 
lymphocyte proliferation and in alloantigen-induced lympho-
cyte proliferation (the mixed lymphocyte reaction) are the !-
region antigens [13]. These antigens are determined by genes 
on the 17th chromosome of the mouse and 6th chromosome of 
man [13]. The fact that both the foreign antigens taken up by 
the macrophage as well as the endogenous histocompatibility 
!-region antigen on the macrophage must be recognized by the 
T lymphocyte for proliferation to occur has led to a frantic 
search for theoretical explanations [14]. The importance of!-
region antigens in these interactions was emphasized by a series 
of experiments in which it was observed that the presence of 
antibodies to the 1-reiion surface antigens of macrophages 
specifically blocked both antigen-induced lymphocyte prolifer-
ation as well as the mixed lymphocyte reaction [15,16]. Thus, 
in the past 20 yr the macrophage has become recognized as a 
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crucial partner in a variety of immunologically specific inter-
actions. 
When it was noted that the Langerhans cells of the epidermis 
consorted with lymphocytes [17], took up antigens and heavy 
metals [18], and possessed Fe and C3 receptors [19], it was 
natural to ask whether the Langerhans cell could function 
immunologically in the same way as a macrophage. The answer, 
in a nutshell, was yes. Considering the fact that cells of the 
epidermis are in the very fust trenches with regard to host 
defense against infectious agents, it is somewhat surprising that 
it took so long for the function of this peculiar macrophage-like 
cell to be established. Identification on the Langerhans cells of 
Fe and C3 receptors led to both a high level of suspicion 
regarding the role of this cell and a convenient means to isolate 
Langer hans cells from other epidermal cells by means of rosette 
techniques. The stage was thus set for Langerhans cells to be 
put through the same immunologic paces as other, more com-
mon immunologic actors. To put it another way, all the tech-
nical advances and tricks learned after 20 yr of in vitro immu-
nologic investigations oflymphocytes and macrophages became 
focused on the function of Langer hans cell. 
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It was very soon established that all Langerhans cells possess 
! -region surface antigens [20,21] (previously shown to be crucial 
for macrophage antigen-presenting functions (22]). Moreover, 
Langerhans cells from guinea pig epidermis act in vitro to 
present exogenous antigens to sensitized lymphocytes, and they 
act in the guinea pig as stimulator cells for mixed lymphocyte 
reactions [23]. Thus, the same laws of histocompatibility re-
striction fust noted for lymphocyte-macrophage interactions 
also were shown to apply to lymphocyte-Langerhans cell inter-
actions. 
The belated recognition of Langerhans cells as epidermal 
macrophages has several important implications. The Langer-
hans cell as the only !a-bearing epidermal cell may be crucial 
for the development and expression of contact sensitivity. In-
creased or decreased Langerhans cell function could be the 
basis of certain skin diseases. Finally, the Langerhans cell in 
allografts could be the chief sensitizing cell; selective and suc-
cessful elimination of all the Langer hans cells from allografts of 
the epidermis might lead to permanent allograft survival [24]. 
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